This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: University of Pennsylvania. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Tullia Lindsten: Innovator in Cell Line Research
Introduction
Tullia Lindsten is a prominent inventor based in Merion, Pennsylvania. She has made significant contributions to the field of cell biology, particularly in the development of immortalized cell lines. Her work has implications for understanding apoptosis and its pathways.
Latest Patents
Tullia Lindsten holds a patent for "Immortalized mouse fibroblast cell lines deficient in Bax and/or Bak." This invention relates to a composition comprising an immortalized cell line that is deficient in the expression of one or more genes of the intrinsic apoptotic pathway, specifically Bax, Bak, and their mixtures. The patent also covers the process for producing these cell lines and methods for identifying compounds that influence the extrinsic apoptotic pathway.
Career Highlights
Tullia is affiliated with the University of Pennsylvania, where she conducts her research. Her innovative work has led to advancements in the understanding of cell survival and death mechanisms, which are crucial for various biomedical applications.
Collaborations
Throughout her career, Tullia has collaborated with notable scientists, including Wei-Xing Zong and Craig B. Thompson. These collaborations have enriched her research and contributed to the advancement of knowledge in the field.
Conclusion
Tullia Lindsten's contributions to cell line research and her innovative patent highlight her role as a leading inventor in the scientific community. Her work continues to influence the understanding of apoptosis and its implications in health and disease.